NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Emkay Global Financial Research Report: SAIL

Key Highlights:

  • Sharp earnings recovery expected for SAIL, with EBITDA/t rising to Rs7,000- 7,500 in the next two quarters (vs ~Rs4,500/t in Q3).
  • Improved realization (+11% for flats and +17% for longs vs Q3) and inventory unwind to drive earnings recovery.
  • Partly offset by higher coking coal costs (+18% QoQ).

Outlook:

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

  • Medium term, improved product mix (Durgapur mill by FY28), better coal blending, and the 4mt IISCO expansion to sustain Rs7,500- 8,000/t EBITDA at USD350/t steel-coking coal spread.
  • Attractive valuations with a price-to-book ratio of 1.1x (vs sector at 2.8x).
  • Target price raised by 14% to Rs200 from Rs175.
  • Recommendation: BUY.

Investor Takeaway

Investors should consider buying SAIL stock due to expected earnings recovery and attractive valuations.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.